Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Hematology

Building Your Care Team and Preparing for Visits

At a Glance

People living with HbE/beta-thalassemia benefit from coordinated care involving a hematologist and specialists in heart health, hormones, transfusion medicine, and genetics. Bringing original test, transfusion, antibody, and MRI records helps the team make safer, informed decisions.

Managing HbE/beta-thalassemia is a lifelong journey that requires more than a standard hematologist; it requires a coordinated team that understands the complex, multi-organ nature of the condition. Because this diagnosis can be easily confused with simple iron deficiency or milder blood traits by those who don’t see it often, finding specialized care is one of the most important steps you can take [1][2].

The Specialized Thalassemia Center

A specialized Thalassemia Center of Excellence (CoE) provides a “medical home” where all your needs are coordinated. Research shows that clinicians at these centers often have deeper, more up-to-date knowledge of the disease than generalists [2]. If a formal center is not available in your area, a strong fallback is local hematology care with periodic telehealth consultations from a recognized thalassemia specialist.

A comprehensive team should include experts who specifically understand how thalassemia affects their area of medicine:

  • Hematologist: The primary doctor who manages transfusions, iron chelation, and overall strategy [3][4].
  • Cardiologist: An expert who monitors for iron-overload cardiomyopathy, arrhythmias, and pulmonary hypertension, and knows how to interpret cardiac T2 MRI* scans [5][6].
  • Endocrinologist: A specialist who monitors growth, puberty, and the health of glands (like the thyroid and pancreas) that are sensitive to iron buildup [7][8].
  • Transfusion Medicine Specialist: A doctor in the blood bank who ensures your blood is “extended matched” to prevent immune reactions [4][9].
  • Genetic Counselor: Someone who can help explain your DNA results and discuss what the diagnosis means for other family members or future pregnancies [10][11].

Preparing for Your First Visit

When you see a new specialist, you are the keeper of your medical history. Bringing your foundational data ensures the new team doesn’t have to guess or repeat expensive tests.

The Essential Records Checklist:

  • Diagnostic Lab Reports: The original HPLC and molecular DNA results. Diagnosis integrates clinical findings with these tests, and having the original molecular reports helps the doctor clearly confirm the genotype [12][11].
  • Transfusion History: A log of every transfusion you have received, including the dates, the volume of blood, and the name of the hospital where it occurred [5][13].
  • Blood Bank “Antibody Screen”: Any historical records of antibodies your immune system has developed against donor blood. This is critical for your safety [14][15].
  • MRI T2 and LIC Reports:* Not just the doctor’s summary, but the actual reports for your liver iron concentration (LIC) and cardiac T2* values [11][16].
  • Growth and Puberty Charts: For children, a record of height and weight over time can tell a specialist a lot about how well the current treatment is working [7][8].

Transitioning from Pediatric to Adult Care

The move from a pediatric doctor to an adult doctor is a high-risk time for patients with thalassemia. Many specialized centers now use a “structured transition” plan, which includes joint meetings between your old and new doctors [11][17].

As you or your child approaches adulthood, look for a team that supports self-advocacy—teaching the patient how to manage their own medications and how to explain their condition to an emergency room doctor [18]. Having a one-page “emergency summary” that lists your diagnosis, baseline hemoglobin, vaccination/spleen status, medications, and antibody history is a vital tool for staying safe during these transitions [5].

Common questions in this guide

Which specialists are usually involved in HbE/beta-thalassemia care?
Care commonly includes a hematologist plus a cardiologist, endocrinologist, transfusion medicine specialist, and genetic counselor. The team should communicate about transfusions, iron monitoring, organ health, genetic results, and long-term planning.
Why might a thalassemia Center of Excellence be helpful?
A specialized center can serve as a medical home where thalassemia care is coordinated by clinicians familiar with the condition. If no center is nearby, a local hematologist may work with a recognized thalassemia specialist through periodic telehealth consultations.
What records should I take to a new thalassemia appointment?
Bring original HPLC and molecular DNA reports, a complete transfusion log, antibody-screen history, actual liver iron concentration and cardiac T2* MRI reports, and growth or puberty charts when relevant. These records help the new team confirm the diagnosis, understand prior care, and avoid unnecessary repeat testing.
Why do transfusion records need antibody history and extended matching?
Past antibodies can affect which donor blood is safest for you. Sharing the complete history helps the blood bank arrange extended red-cell matching, including C, c, E, e, and Kell antigens, to reduce the risk of immune reactions.
How can cardiac T2* MRI results affect HbE/beta-thalassemia care?
Cardiac T2* MRI helps the care team assess iron in the heart. A cardiologist and hematologist can use the results, along with other iron measurements, when reviewing the iron-chelation plan.
How should a child transition from pediatric to adult thalassemia care?
A structured transition may include meetings between the pediatric and adult teams, teaching the patient to manage medicines and explain the condition, and creating a one-page emergency summary. The summary can list the diagnosis, baseline hemoglobin, vaccination and spleen status, medicines, and antibody history.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Hemoglobin E-beta-thalassemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is this facility formally recognized as a Thalassemia Center of Excellence, or do you coordinate with one for specialized consultation?
  2. 2.How many patients with the specific HbE/beta-thalassemia genotype do you currently manage in your practice?
  3. 3.Do you coordinate directly with the blood bank to ensure I receive extended red-cell matching (for C, c, E, e, and Kell) for every transfusion?
  4. 4.Do you have a specialized protocol for interpreting cardiac T2* MRI results, and how do those results specifically change my chelation plan?
  5. 5.If my child is currently pediatric, do you have a formal, structured transition plan to move them to an adult hematologist who has the same level of thalassemia expertise?

References

References (18)
  1. 1

    2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.

    Farmakis D, Porter J, Taher A, et al.

    HemaSphere 2022; (6(8)):e732 doi:10.1097/HS9.0000000000000732.

    PMID: 35928543
  2. 2

    An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.

    Stacy S, Sheth S, Coleman B, Cerenzia W

    Annals of hematology 2021; (100(1)):27-35 doi:10.1007/s00277-020-04246-5.

    PMID: 32870368
  3. 3

    Increasing prevalence of thalassemia in America: Implications for primary care.

    Sayani FA, Kwiatkowski JL

    Annals of medicine 2015; (47(7)):592-604 doi:10.3109/07853890.2015.1091942.

    PMID: 26541064
  4. 4

    Challenges in chronic transfusion for patients with thalassemia.

    Lal A

    Hematology. American Society of Hematology. Education Program 2020; (2020(1)):160-166 doi:10.1182/hematology.2020000102.

    PMID: 33275743
  5. 5

    Beyond the blood: A practical guide to thalassemia care in the emergency department.

    Mufarrij A, Hodroj MH, Charbel N, et al.

    Blood reviews 2025; (74()):101327 doi:10.1016/j.blre.2025.101327.

    PMID: 40769855
  6. 6

    Iron overload status in patients with non-transfusion-dependent thalassemia in China.

    Huang Y, Yang G, Wang M, et al.

    Therapeutic advances in hematology 2022; (13()):20406207221084639 doi:10.1177/20406207221084639.

    PMID: 35321211
  7. 7

    Spectrum of Adrenal Dysfunction in Hemoglobin E/Beta Thalassemia.

    Singha A, Mukhopadhyay P, Ghosh S

    The Journal of clinical endocrinology and metabolism 2024; (109(2)):e562-e568 doi:10.1210/clinem/dgad579.

    PMID: 37772731
  8. 8

    Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.

    Inati A, Noureldine MA, Mansour A, Abbas HA

    BioMed research international 2015; (2015()):813098 doi:10.1155/2015/813098.

    PMID: 25834825
  9. 9

    Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.

    Compernolle V, Chou ST, Tanael S, et al.

    Transfusion 2018; (58(6)):1555-1566 doi:10.1111/trf.14611.

    PMID: 29697146
  10. 10

    Best Practices for Thalassaemia Management: Recommendations by Indian Society of Haematology and Blood Transfusion.

    Dolai TK, Jena RK, Roy S, et al.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2026; (42(3)):679-696 doi:10.1007/s12288-026-02390-y.

    PMID: 42040714
  11. 11

    Diagnosis and Management of Transfusion-Dependent Thalassemia: Evidence-Based Guidelines From the Pediatric Hematology Oncology Chapter of the Indian Academy of Pediatrics.

    Radhakrishnan N, Dewan P, Chandra J, et al.

    Indian pediatrics 2026; (63(9)):612-637 doi:10.1007/s13312-026-00366-9.

    PMID: 42490030
  12. 12

    Precision Medicine in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia: Toward Personalized Diagnosis and Therapy.

    Karen AA, Tluli O, Hashem IE, et al.

    Hemoglobin 2026; (50(5)):405-413 doi:10.1080/03630269.2026.2709700.

    PMID: 42572810
  13. 13

    Transfusion practices and complications in thalassemia.

    Lal A, Wong TE, Andrews J, et al.

    Transfusion 2018; (58(12)):2826-2835 doi:10.1111/trf.14875.

    PMID: 30260477
  14. 14

    Challenges of blood transfusions in β-thalassemia.

    Shah FT, Sayani F, Trompeter S, et al.

    Blood reviews 2019; (37()):100588 doi:10.1016/j.blre.2019.100588.

    PMID: 31324412
  15. 15

    Characterization of pediatric transfusion-dependent thalassemia patients in a large academic center.

    Zarrabian D, Hanna M

    Journal of clinical laboratory analysis 2023; (37(17-18)):e24962 doi:10.1002/jcla.24962.

    PMID: 37665129
  16. 16

    Delayed recognition and significant morbidity in adults with non-transfusion-dependent thalassemia.

    Cheng AN, Peslak S, Sheth S, et al.

    Blood advances 2026; (10(18)):6051-6059 doi:10.1182/bloodadvances.2026020059.

    PMID: 42314035
  17. 17

    Transition from Pediatric to Adult Care in Patients with Transfusion-Dependent Beta-Thalassemia in France: A National Study Concerning a Rare Disease.

    Szepetowski S, Benoit A, Berbis J, et al.

    Journal of clinical medicine 2026; (15(6)) doi:10.3390/jcm15062203.

    PMID: 41899126
  18. 18

    Transfer of Care for People with Severe Forms of Thalassemia: Learning from Past Experiences to Create a Transition Plan.

    Morse LA, Sawh RN

    Journal of pediatric nursing 2021; (61()):378-386 doi:10.1016/j.pedn.2021.08.007.

    PMID: 34600243

This page provides general information about coordinating care for HbE/beta-thalassemia and preparing for specialist visits; it is for informational purposes only and does not constitute medical advice. Your hematology team should tailor records, transfusions, monitoring, and transition plans to your needs.